Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2021
Biosimilar follitropin alfa on the PBS - information for health care professionals and patients
7 December 2021 - A biosimilar brand of follitropin alfa (Ovaleap) was listed on the PBS on 1 December 2021. ...
Posted by Michael Wonder on 05 Dec 2021
PBS in review (2021)
5 December 2021 - We review the new medicines listed on the PBS in 2021. ...
Posted by Michael Wonder on 03 Dec 2021
Agenda for the December 2021 PBAC intracycle meeting
3 December 2021 - The agenda for the December 2021 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 02 Dec 2021
Strengthening patient access to new medicines through new landmark Bill
2 December 2021 - Australians will see improved access to new and innovative medicines, vaccines and treatments as a landmark ...
Posted by Michael Wonder on 02 Dec 2021
DoH revises agenda for March 2022 PBAC meeting twice in one day!
2 December 2021 - Version 3 came and went quickly; the current version (version 4) makes no reference to the ...
Posted by Michael Wonder on 30 Nov 2021
Schedule of Pharmaceutical Benefits - 1 December 2021
1 December 2021 - The December 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Nov 2021
Updated 2021 – 22 cost recovery implementation statement
30 November 2021 - The 2021-22 Pharmaceutical Benefits Scheme and National Immunisation Plan Cost Recovery Implementation Statement has been updated ...
Posted by Michael Wonder on 28 Nov 2021
New treatment for Australians with leukaemia
28 November 2021 - From 1 December 2021, Australians with acute myeloid leukaemia will have access to a new treatment option ...
Posted by Michael Wonder on 27 Nov 2021
Here we go again - version 2.0
26 November 2021 - The agenda for the March 2022 PBAC agenda has been revised within 48 hours of publication. ...
Posted by Michael Wonder on 26 Nov 2021
Additional insights from the agenda for the March 2022 PBAC meeting
26 November 2021 - More insights from the MAESTrO Team. ...
Posted by Michael Wonder on 25 Nov 2021
Insights from the agenda (version 1.0) for the March 2022 PBAC meeting
26 November 2021 - Some insights from the MAESTrO Team. ...
Posted by Michael Wonder on 25 Nov 2021
Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
Posted by Michael Wonder on 25 Nov 2021
Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies
25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...
Posted by Michael Wonder on 24 Nov 2021
Agenda for the March 2022 PBAC meeting
24 November 2021 - The agenda for the March 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 24 Nov 2021
Semaglutide (Wegovy) stakeholder meeting outcome statement
24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...